StreetAlpha.app
Home › Stocks › DRUG

Bright Minds Biosciences Inc. (DRUG)

$20.40
▼ −1.45%
LAST CLOSE · NOV 20

Bright Minds Biosciences Inc. (DRUG) tracked by StreetAlpha. It last closed at $20.40 on Nov 20, down 1.45% on the day. Over the last 12 months DRUG insiders bought $0 of stock on the open market and sold $9.8M, according to SEC Form 4 filings.

AI Auto Pilots
Is DRUG in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DRUG.

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on DRUG
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on DRUG

Technical Analysis

DRUG · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 48% below its 20 day and 118% below its 50 day average. It is 237% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the swing low (Nov 17) at $19.86, and the nearest resistance the Pivot at $20.66.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 17.6%/day
Key levels
$123.7552 week high+506.6%
$68.72200 day average+236.9%
$59.37100 day average+191.0%
$44.5150 day average+118.2%
$30.1820 day average+47.9%
$24.28Swing high (Nov 16)+19.0%
$21.30Pivot R1+4.4%
$20.66Pivot+1.3%
$20.40Last close
$19.86Swing low (Nov 17)−2.6%
$19.76Pivot S1−3.1%
$17.4052 week low−14.7%
Indicators
RSI (14)26.77Oversold below 30Oversold
MACD-7.99Above its signal lineBullish
Stochastic22.4Middle of its rangeNeutral
ADX (14)46.7Strong downtrend
Williams %R-67.7Oversold below −80, overbought above −20Neutral
CCI (20)-52.6Oversold below −100, overbought above 100Neutral
Rate of change−11.3%Change over 10 sessionsBearish
ATR (14)$3.60Typical daily range, 17.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DRUG

What happened before

See how DRUG did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow DRUG usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How DRUG has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for DRUGHow many large options trades hit DRUG, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

DRUG Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●46 buying vs 45 selling
  • ▼Shares held by funds -3.4%
  • ▲Funds holding +10
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding110100+10.0%
In funds' top 1012−50.0%
Held by funds–––
New / increased17 / 2919 / 47−30.3%
Reduced / sold out37 / 817 / 12+55.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DRUG institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

DRUG Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$9.8M1 sale · 1 insider
2026-04 sold $9.8MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Apr 28Cormorant Asset Management, LPFormer 10% OwnerSale109,331$89.50$9.8M
Every insider buy and sale for DRUG over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See DRUG insider trades →

From SEC Form 4 filings by DRUG's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DRUG is in one of them and how their past DRUG trades turned out.

DRUG in the AI portfolios
Loading…

DRUG News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DRUG in an article yet. Here's the latest on the wider market.

DRUG in the news